gold has been researched along with maytansine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Barrientos, A; Conlon, K; Coulter, T; Damment, S; Ding, Y; Garcı A, CE; Hale, SJM; Pace, A; Patel, KR; Peral, U; Perera, I; Perrins, RD; Porter, J; Robinson, A; Rodriguez, MÁ; Saito, G; Williams, P | 1 |
Conlon, K; Coulter, T; Ding, Y; Hale, SJM; Ma, Y; Mazanetz, MP; Perrins, RD; Porter, J; Robinson, A; Wu, Y | 1 |
Chen, D; Ding, Y; He, D; Liu, Y; Shen, Y; Tu, J; Wang, R; Xu, P; Yang, W; Ye, Z | 1 |
3 other study(ies) available for gold and maytansine
Article | Year |
---|---|
DM1 Loaded Ultrasmall Gold Nanoparticles Display Significant Efficacy and Improved Tolerability in Murine Models of Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Models, Animal; Drug Carriers; Female; Gold; Humans; Liver Neoplasms; Maytansine; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Particle Size; Xenograft Model Antitumor Assays | 2019 |
A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Gold; Humans; Liver Neoplasms; Maytansine; Mice; Models, Molecular; Nanoconjugates; Tubulin Modulators | 2020 |
A DM1-doped porous gold nanoshell system for NIR accelerated redox-responsive release and triple modal imaging guided photothermal synergistic chemotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Drug Liberation; Drug Tapering; Drug Therapy; Female; Gold; Humans; Macrophages; Maytansine; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Nanoshells; Oxidation-Reduction; Photothermal Therapy; Polyethylene Glycols; Porosity; Receptor, ErbB-2 | 2021 |